Skip to main content

Table 6 Cost-per averted DALY (USD) by Decrease in PrEP prices and % of non-UAI users stopping Condom use on receiving PrEP

From: Cost utility analysis of HIV pre exposure prophylaxis among men who have sex with men in Israel

% non-UAI stopping condom use

Decrease in PrEP prices

BEP price decrease

 

10%

50%

70%

90%

0%

849,172

472,124

283,601

95,077

87.2%

25%

882,020

493,246

298,859

104,471

88.2%

50%

916,977

515,723

315,096

114,469

89.3%

75%

954,254

539,692

332,410

125,129

90.3%

  1. Notes: Assuming 10% of high-risk users who receive PrEP also start using condoms
  2. Assumes 80% PrEP take up by high-risk MSM,
  3. 25% PrEP take up by low-risk MSM
  4. PrEP efficacy of 86.0% [4, 5]
  5. Based on MOH payment schedule to HMOs for HIV/AIDS patients
  6. BEP = Break Even Point (price decrease) for cost-effectiveness